case_images: PMC11724419_01
case_images: (a, b) At baseline, multiple exudating nodules, abscesses, and retracting scars in the right axilla and groin.
case_images: 10.1177_2050313X241311374-fig1.jpg
case_images: PMC11724419_01_10.1177_2050313X241311374-fig1.jpg
case_images: fig1-2050313X241311374
case_images: (a, b) After 6 weeks of therapy with certolizumab pegol, significant improvement of lesions: absence of nodules, and persistence of residual sinus tracts and retracting scars.
case_images: 10.1177_2050313X241311374-fig2.jpg
case_images: PMC11724419_01_10.1177_2050313X241311374-fig2.jpg
case_images: fig2-2050313X241311374
case_images: At week 8, a meaningful improvement of axillary and inguinal lesions was appreciated (physician global assessment = 3) as well as a reduction in pain (NRS = 5 out of 10) and improvement in quality of life (DLQI = 8 out of 30) (Figure 2(a) and (b)).